Massimo Puoti

22.3k citations
442 papers · 17.2k · 7 hit papers · h-index 57

Impact in

  • Hepatology top 0.05%
    • Hepatitis C virus research
    • Hepatocellular Carcinoma Treatment and Prognosis
  • Virology top 1%
    • HIV Research and Treatment

Papers in

    • Hepatitis C virus research 225
    • HIV/AIDS drug development and treatment 51
    • COVID-19 Clinical Research Studies 29
    • HIV/AIDS Research and Interventions 20

Massimo Puoti

421 papers receiving 16.5k citations

Massimo Puoti's Hit Papers

EASL recommendations on treatment of hepatitis C: Final update of the series☆ 2020 · 902 citations
9020+6+12Years since publication5001k1.5k

Peers

Massimo Puoti
Comparison fields: 5 of 135
  • Hepatology 9.4k
  • Virology 696
  • Infectious Diseases 2.6k
  • Epidemiology 3.8k
  • Emergency Medicine 379
Replace Diana M. Brainard with:
Diana M. Brainard United States
Mark Sulkowski United States
Giampiero Carosi Italy
Mark J. DiNubile United States
Jacob Paul Lalezari United States
Francesca J. Torriani United States
Sanjay R. Bhagani United Kingdom
Gail V. Matthews Australia
Robert H. Hyland United States
Shyam Kottilil United States
Massimo Puoti relative to Diana M. Brainard United States Diana M. Brainard's profile →
Citations per field
00.5×2×4×5.4×
Diana M. Brainard · 1×
Citations per year

Countries citing papers authored by Massimo Puoti

Since Specialization
Citations

This map shows the geographic impact of Massimo Puoti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Puoti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Puoti more than expected).

Fields of papers citing papers by Massimo Puoti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Puoti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Puoti. The network helps show where Massimo Puoti may publish in the future.

Co-authors

The 25 scholars most cited alongside Massimo Puoti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Massimo Puoti Line = papers co-authored together Massimo Puoti links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 442 papers — load more, or switch the sort, to bring in the rest.

#Work
1
EASL Recommendations on Treatment of Hepatitis C 2018
Hit paper breakdown →
20181759
2
Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
Hit paper breakdown →
20141454
3
EASL recommendations on treatment of hepatitis C: Final update of the series☆
Hit paper breakdown →
2020902
4
Statements from the Taormina expert meeting on occult hepatitis B virus infection
Hit paper breakdown →
2008696
5 1998459
6
Update of the statements on biology and clinical impact of occult hepatitis B virus infection
Hit paper breakdown →
2019414
7
Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection
Hit paper breakdown →
2018340
8 2011336
9
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials
Hit paper breakdown →
2018313
10 1991292
11 2007270
12 2003232
13 2004210
14 2008207
15 2000203
16 2004196
17 2007188
18 2005182
19 2008179
20 2001176

About Massimo Puoti

Massimo Puoti is a scholar working on Hepatology, Infectious Diseases, Epidemiology, Virology and Emergency Medicine, having authored 442 papers that have together received 17.2k indexed citations. Recurring topics across this work include Hepatitis C virus research (225 papers), Hepatitis B Virus Studies (63 papers), HIV/AIDS drug development and treatment (51 papers), COVID-19 Clinical Research Studies (29 papers), HIV/AIDS Research and Interventions (20 papers), HIV Research and Treatment (16 papers), HIV-related health complications and treatments (12 papers) and Liver Disease Diagnosis and Treatment (10 papers). The work is most often cited by research in Hepatology (9.4k citations), Virology (696 citations), Infectious Diseases (2.6k citations), Epidemiology (3.8k citations) and Emergency Medicine (379 citations). Massimo Puoti has collaborated with scholars based in Italy, United Kingdom and Spain. Frequent co-authors include Heiner H. Wedemeyer, Francesco Negro, Alessio Aghemo, Geoffrey M Dusheiko, Marina Berenguer, Olav Dalgård, Jean–Michel Pawlotsky, Fiona Marra, Francesco Donato and Vincent Soriano. Their work appears in journals such as Journal of Hepatology, Digestive and Liver Disease, Journal of Antimicrobial Chemotherapy, Clinical Infectious Diseases and Liver International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact